Biomarkers

R&D

The role of bioanalysis as the foundation of precision medic...

Precision medicine, also known as personalised medicine, is transforming healthcare by providing tailored treatments to patients suffering from life-threatening conditions.

R&D

Precision medicine, NGS, and the quantum leap in biomarkers

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company

Oncology

Strategies for commercialising oncology treatments for young...

The oncology landscape is evolving, with a marked rise in cancer incidence among young adults globally.

News

WCLC: Biomarker could guide Dato-DXd use in lung cancer

A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dat

R&D

Harnessing genetics to propel cancer research and clinical s...

When navigating the landscape of pharmaceutical development, clinical trials represent both a crucial checkpoint and a formidable barrier.

News

Blood test could spot Parkinson’s years earlier

An artificial intelligence-powered blood test that may be able to predict Parkinson’s disease several years before symptoms start to develop could allow earlier treatment and help guide the